홈 > 시장보고서 > 재료/화학 > 나노테크놀러지

시장보고서

상품코드

2132569

DNA 나노기술 시장 규모, 점유율, 동향 분석 보고서 : 기술 유형별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)

DNA Nanotechnology Market Size, Share & Trends Analysis Report By Technology Type (Dynamic DNA Nanotechnology, Structural DNA Nanotechnology), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

발행일: 2026년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

가격

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,950

￦ 8,149,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 6,950

￦ 9,518,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 8,950

￦ 12,257,000

※ 부가세 별도

한글목차

영문목차

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

DNA 나노기술 시장 요약

세계의 DNA 나노기술 시장 규모는 2025년에 53억 달러로 평가되며, 2026년 63억 달러에서 2033년에는 242억 달러로 성장할 것으로 예상되며, 2026년부터 2033년까지 CAGR 21.1%로 확대될 것으로 예측됩니다.

북미가 시장을 주도하고 있으며, 2025년에는 매출 점유율의 59.1%를 차지했습니다. 시장의 성장은 표적 약물전달, 첨단 진단 및 맞춤형 의료 분야의 응용 확대에 의해 주도되고 있습니다.

연구개발(R&D) 투자 증가, 나노 디바이스 설계에 AI 통합, 그리고 혁신적인 헬스케어 솔루션에 대한 수요 증대가 세계 시장의 추가 확장을 뒷받침하고 있습니다.

The global DNA nanotechnology market size was valued at USD 5.3 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 24.2 billion by 2033, at a CAGR of 21.1% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 59.1% 2025. The market growth is driven by increasing applications in targeted drug delivery, advanced diagnostics, and personalized medicine.

Rising R&D investments, integration of AI in nanodevice design, and growing demand for innovative healthcare solutions are further fueling global market expansion.

Global DNA Nanotechnology Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global DNA nanotechnology market on the basis of technology type, application, end use, and region.

Technology Type Outlook (Revenue, USD Million, 2021 - 2033)
Dynamic DNA Nanotechnology
- Extended Lattices
- Discrete Structures
- Template Assembly
- Others
Structural DNA Nanotechnology
- Nanomechanical Devices
- Strand Displacement Cascades
- Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Drug Delivery Systems
Diagnostics and Biosensing Development
Material Science and Nanoassembly
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutions
Biotechnology and Pharmaceuticals
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
Latin America
- Brazil
- Argentina
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Technology Type
- 1.2.2. Application
- 1.2.3. End Use
1.3. Research Methodology
1.4. Information Procurement
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. DNA Nanotechnology Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Advancements in DNA Origami and Self-Assembly Technologies
  - 3.2.1.2. Rising Applications in Drug Delivery and Cancer Therapeutics
  - 3.2.1.3. Growing adoption of precision medicine and targeted drug delivery
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. High Cost of DNA Synthesis and Nanostructure Fabrication
  - 3.2.2.2. Complex regulatory pathways for clinical applications
3.3. DNA Nanotechnology Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Economic landscape
  - 3.3.2.5. Legal landscape

Chapter 4. DNA Nanotechnology Market: Technology Type Estimates & Trend Analysis

4.1. Technology Type Segment Dashboard
4.2. Global DNA Nanotechnology Market Technology Type Movement Analysis
4.3. Global DNA Nanotechnology Market Size & Trend Analysis, by Technology Type, 2021 to 2033 (USD Million)
4.4. Dynamic DNA Nanotechnology
- 4.4.1. Dynamic DNA Nanotechnology Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.4.2. Extended Lattices
  - 4.4.2.1. Extended Lattices Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.4.3. Discrete Structures
  - 4.4.3.1. Discrete Structures Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.4.4. Template Assembly
  - 4.4.4.1. Template Assembly Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.4.5. Others
  - 4.4.5.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)
4.5. Structural DNA Nanotechnology
- 4.5.1. Structural DNA Nanotechnology Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.5.2. Nanomechanical Devices
  - 4.5.2.1. Nanomechanical Devices Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.5.3. Strand Displacement Cascades
  - 4.5.3.1. Strand Displacement Cascades Market Estimates and Forecasts 2021 to 2033 (USD Million)
- 4.5.4. Others
  - 4.5.4.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 5. DNA Nanotechnology Market: Application Estimates & Trend Analysis

5.1. Application Segment Dashboard
5.2. Global DNA Nanotechnology Market Application Movement Analysis
5.3. Global DNA Nanotechnology Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
5.4. Drug Delivery Systems
- 5.4.1. Drug Delivery Systems Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.5. Diagnostics and Biosensing Development
- 5.5.1. Diagnostics and Biosensing Development Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.6. Material Science and Nanoassembly
- 5.6.1. Material Science and Nanoassembly Market Estimates and Forecasts 2021 to 2033 (USD Million)
5.7. Others
- 5.7.1. Others Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 6. DNA Nanotechnology Market: End Use Estimates & Trend Analysis

6.1. End Use Segment Dashboard
6.2. Global DNA Nanotechnology Market End Use Movement Analysis
6.3. Global DNA Nanotechnology Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Academic & Research Institutions
- 6.4.1. Academic & Research Institutions Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.5. Biotechnology and Pharmaceuticals
- 6.5.1. Biotechnology and Pharmaceuticals Market Estimates and Forecasts 2021 to 2033 (USD Million)
6.6. Other
- 6.6.1. Other Market Estimates and Forecasts 2021 to 2033 (USD Million)

Chapter 7. DNA Nanotechnology Market: Regional Estimates & Trend Analysis

7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. North America
- 7.3.1. U.S.
  - 7.3.1.1. Key country dynamics
  - 7.3.1.2. Regulatory framework
  - 7.3.1.3. Competitive scenario
  - 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.2. Canada
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.3. Mexico
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. France
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.6. Norway
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.3. India
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 7.6.2. Argentina
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
7.7. MEA
- 7.7.1. South Africa
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

8.1. Company/Competition Categorization
8.2. Company Position Analysis, 2025
8.3. Strategy Mapping
8.4. Company Profiles/Listing
- 8.4.1. GATTAquant GmbH
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. NanoBio Designs, Inc.
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Tilibit Nanosystems
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Helixworks
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. SomaLogic Operating Co., Inc.
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. EnaChip Inc.
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. Ginkgo Bioworks
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Nanolab Technologies (acquired by Eurofins Scientific)
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Nanogami
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. DNA Nanobots, Inc.
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격